Tramadol versus Buprenorphine for the Treatment of Opiate Withdrawal: A Retrospective Cohort Control Study

Journal of Addictive Diseases

Volumn 22, Issue 4, 2003, Pages 5-12

  Tamaskar, Ranjit ^a   Parran Jr , Theodore V ^b,c   Heggi, Abdul ^a   Brateanu, Andrei ^a   Rabb, Mary ^b   Yu, Jaehak ^c  

^a Huron Hospital   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Buprenorphine therapeutic use; Cohort studies; Heroin withdrawal management; Medical detoxification; Tramadol therapeutic use

Indexed keywords

BUPRENORPHINE; CLONIDINE; DIAMORPHINE; DICYCLOVERINE; HYDROXYZINE; METHADONE; MU OPIATE RECEPTOR; TRAMADOL;

ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMMUNITY CARE; CONTROLLED STUDY; DETOXIFICATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEROIN DEPENDENCE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTPATIENT; RETROSPECTIVE STUDY; TREATMENT FAILURE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; COHORT STUDIES; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; NARCOTIC ANTAGONISTS; RETROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME; TRAMADOL;

EID: 0842266611     PISSN: 10550887     EISSN: None     Source Type: Journal    
DOI: 10.1300/J069v22n04_02     Document Type: Article

References (24)

1. Office of Applied Studies, 1998. National Household Survey on Drug Abuse: Population Estimates 1997, No. (SMA) 98-3200. Substance Abuse and Mental Health Services Administration, Rockville, MD.
2. Office of Applied Studies, 1999a. Year-End 1997 Emergency Department Data from the Drug Abuse Warning Network, No. D-6. Substance Abuse and Mental Health Services Administration, Rockville, MD. pp. 17-18.
3. Office of Applied Studies, 1999b. Treatment Episode Data Set (TEDS): 1992-1997, Substance Abuse and Mental Health Services Administration, Rockville, MD.
4. Guthrie SK. Pharmacologic interventions for the treatment of opioid dependence and withdrawal. DICP 1990;24:721-34.
5. Weaver MF, Jarvis MAE, Schnoll SH. Role of the primary care physician in problems of substance abuse. Arch Intern Med 1999;159:913-24.
6. O'Connor PG, Kosten TR, Ziedonis D, et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med 1998;105:100-5.
7. Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J. Burenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis 1993;181:358-64.
8. Kosten TR, Schottenfeld R, Ziedonis D, et al. Opioid antagonist challenges in buprenorphine maintained patients. Drug Alcohol Depend 1990;25(1):73-8.
9. Umbricht A. Naltrexone shortened opioid detoxification with buprenorphine. Drug and Alc Dep 1999;56:181-90.
10. Fudala PJ, Jaffe JH, Dax EM, Johnson RE. Use of buprenorphine in the treatment of opioid addiction: the physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol 1990;47:525-34.
11. San L, Cami J, Fernandez T. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects. Br J Addict 1992;87:55-62.
12. Parran TV, Adelman CL, Jasinski DR. Buprenorphine detoxification of medically unstable narcotic dependent patients. Subst Abuse 1990;11:197-202.
13. Parran T, Adelman CL, Jasinski D. The Use of a buprenorphine stabilization and rapid taper protocol in the detoxification of medically unstable narcotic dependent patients. Am J Addictions 1994;3:306-13.
14. O'Connor PG, Kosten TR. Rapid and ultrarapid opioid detoxification techniques. JAMA 1998;279:229-34.
15. Stine SM, Meandzija B, Kosten TR. Pharmacologic Therapies for Opioid Addiction, in Principles of Addiction Medicine. Graham AW, Schultz TK, eds. American Society of Addiction Medicine. Chevy Chase, MD. 1998.
16. Tramadol: a new drug for pain. The Medical Letter 1995;37:59-60.
17. Bamigbade TA, Langford RM. Tramadol hydrochloride: an overview of current use. Hosp Med 1998;59:373-6.
18. Cami J, Lamas X, Farre M. Acute effects of tramadol in methadone-maintained volunteers. Drugs 1994;(S1):30-34.
19. Preston KL, Jasinski DR, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alc Depend 1991;27:7-10.
20. Miranda HF, Pinardi G. Antinociception, tolerance, and physical dependence comparison between morphine and tramadol. Pharmacol Biochem Behav 1998;61: 357-60.
21. Ehrenreich H, Poser W. Dependence on tramadol. Clin Investig 1993;26:72-6.
22. Meyer FP, Rimasch H, Blaha B, Banditt P. Tramadol withdrawal in a neonate. Eur J Clin Pharmacol 1997;53:159-60.
23. Peachey JE, Lei H. Assessment of opioid dependence with naloxone. Br J Addict 1988;83:193-7.
24. O'Connor PG, Waugh ME, Schottenfeld RS. Ambulatory opiate detoxification and primary care. J Gen Int Med 1992;7:532-4.